Author

István Tornai 1

1 Institute of Medicine,

GUT BARRIER FAILURE BIOMARKERS ARE ASSOCIATED WITH POOR DISEASE OUTCOME IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS

Tornai Tamás, György Kovács, Zsuzsanna Vitális, István Tornai, Kai Fechner, Dirk Roggenbuck, David Tornai, Gary L. Norman, Gabor Laszlo Veres, Zakera Shums, Péter Orosz, Béla Lombay, Judit Gervain, Gabriella Par, Alajos Pár, Peter L Lakatos, Ferenc Szalay, Peter Antal-Szalmas, Mária Papp

IGA ANTIBODIES AGAINST FILAMENTOUS-ACTIN ARE FREQUENTLY DETECTED IN PATIENTS WITH CIRRHOSIS AND INDICATE A PROGRESSIVE DISEASE COURSE

Tornai Tamás, Boglarka Balogh, Nora Sipeki, Zsuzsanna Vitális, István Tornai, Peter Antal-Szalmas, Gary L. Norman, Tony Bruns, Mária Papp

PRESEPSIN AS A NEW BIOMARKER FOR OLD EXPECTATIONS IN THE DIAGNOSIS AND PROGNOSIS OF BACTERIAL INFECTION IN CIRRHOSIS

Mária Papp, Tornai Tamás, David Tornai, Zsuzsanna Vitális, István Tornai, Peter L Lakatos, Peter Antal-Szalmas

SERUM LEVELS OF LECTIN COMPLEMENT PATHWAY MOLECULES DO NOT PRIMARILY DETERMINE THE RISK OF BACTERIAL INFECTIONS IN PATIENTS WITH CIRRHOSIS

Ildikó Földi, David Tornai, Tornai Tamás, Zsuzsanna Vitális, István Tornai, Tamas Dinya, Peter Antal-Szalmas, Mária Papp

SOLUBLE CD163 (SCD163) IS A MARKER OF INFECTION IN PATIENTS WITH CIRRHOSIS AND ACUTE DECOMPENSATION AND AN INDEPENDENT PREDICTOR OF THE SHORT-TERM MORTALITY

Tornai Tamás, David Tornai, Zsuzsanna Vitális, István Tornai, Peter Antal-Szalmas, Mária Papp

TARGET-SPECIFIC ANTI-PANCREATIC ANTIBODIES ARE FREQUENT IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS AND ASSOCIATED WITH POOR DISEASE OUTCOME

Mária Papp, Tornai Tamás, Nora Sipeki, Zsuzsanna Vitális, István Tornai, Kai Fechner, Dirk Roggenbuck, David Tornai, Gary L. Norman, Zakera Shums, Gabor Laszlo Veres, Péter Orosz, Béla Lombay, Judit Gervain, Gabriella Par, Alajos Pár, Peter L Lakatos, Ferenc Szalay, Peter Antal-Szalmas

Item 1 - 6 / 11
1
2